Xiaoxian Li1, Zhongliang Ma2, Toncred M Styblo3, Cletus A Arciero3, Haibo Wang2, Michael A Cohen4. 1. Department of Pathology and Laboratory Medicine, Emory University, 1364 Clifton Road, Atlanta, GA, 30322, USA. xli40@emory.edu. 2. Breast Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, China. 3. Department of Surgery, Emory University, Atlanta, GA, USA. 4. Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Road, Atlanta, GA, 30322, USA. Michael.cohen@emoryhealthcare.org.
Abstract
BACKGROUND: The management of high-risk breast lesions diagnosed on image-guided core biopsy remains controversial. We implemented a high-risk breast conference attended by breast pathologists, imagers, and surgeons to prospectively review all contemporary cases in order to provide a consensus recommendation to either surgically excise or follow on imaging at 6-month intervals for a minimum of 2 years. METHODS: Between May, 2015 and June, 2019, 127 high-risk lesions were discussed. Of these 127 cases, 116 had concordant radiology-pathology (rad-path) findings. The remaining 11 patients had discordant rad-path findings. Of the 116 concordant cases, 6 were excluded due to lack of the first imaging follow-up until analysis. Of the remaining 110 patients, 43 had atypical ductal hyperplasia (ADH), 12 had lobular carcinoma in situ (LCIS), 19 had atypical lobular hyperplasia (ALH), 33 had radial scar (RS), 2 had flat epithelial atypia (FEA), and 1 had mucocele-like lesion (ML). We recommended excision for ADH if there were > 2 ADH foci or < 90% of the associated calcifications were removed. For patients with LCIS or ALH, we recommended excision if the LCIS or ALH was associated with microcalcifications or the LCIS was extensive. We recommended excision of RS when < 1/2 of the lesion was biopsied. We recommended all patients with FEA and ML for 6-month follow-up. RESULTS: Following conference-derived consensus for excision, of the 27 ADH excised, 9 were upgraded to invasive carcinoma or ductal carcinoma in situ. Of the six LCIS cases recommended for excision, none were upgraded. Nine excised radial scars revealed no upgrades. Additionally, 3 patients with ADH, 2 with ALH, 1 with LCIS, and 2 with RS underwent voluntary excision, and none were upgraded. All other patients (13 with ADH, 5 LCIS, 17 ALH, 22 RS, 2 FEA and 1 ML) were followed with imaging, and none revealed evidence of disease progression during follow-up (187-1389 days). All 11 rad-path discordant cases were excised with 2 upgraded to carcinoma. CONCLUSIONS: The results of this prospective study indicate that high-risk breast lesions can be successfully triaged to surgery versus observation following establishment of predefined firm guidelines and performance of rigorous rad-path correlation.
BACKGROUND: The management of high-risk breast lesions diagnosed on image-guided core biopsy remains controversial. We implemented a high-risk breast conference attended by breast pathologists, imagers, and surgeons to prospectively review all contemporary cases in order to provide a consensus recommendation to either surgically excise or follow on imaging at 6-month intervals for a minimum of 2 years. METHODS: Between May, 2015 and June, 2019, 127 high-risk lesions were discussed. Of these 127 cases, 116 had concordant radiology-pathology (rad-path) findings. The remaining 11 patients had discordant rad-path findings. Of the 116 concordant cases, 6 were excluded due to lack of the first imaging follow-up until analysis. Of the remaining 110 patients, 43 had atypical ductal hyperplasia (ADH), 12 had lobular carcinoma in situ (LCIS), 19 had atypical lobular hyperplasia (ALH), 33 had radial scar (RS), 2 had flat epithelial atypia (FEA), and 1 had mucocele-like lesion (ML). We recommended excision for ADH if there were > 2 ADH foci or < 90% of the associated calcifications were removed. For patients with LCIS or ALH, we recommended excision if the LCIS or ALH was associated with microcalcifications or the LCIS was extensive. We recommended excision of RS when < 1/2 of the lesion was biopsied. We recommended all patients with FEA and ML for 6-month follow-up. RESULTS: Following conference-derived consensus for excision, of the 27 ADH excised, 9 were upgraded to invasive carcinoma or ductal carcinoma in situ. Of the six LCIS cases recommended for excision, none were upgraded. Nine excised radial scars revealed no upgrades. Additionally, 3 patients with ADH, 2 with ALH, 1 with LCIS, and 2 with RS underwent voluntary excision, and none were upgraded. All other patients (13 with ADH, 5 LCIS, 17 ALH, 22 RS, 2 FEA and 1 ML) were followed with imaging, and none revealed evidence of disease progression during follow-up (187-1389 days). All 11 rad-path discordant cases were excised with 2 upgraded to carcinoma. CONCLUSIONS: The results of this prospective study indicate that high-risk breast lesions can be successfully triaged to surgery versus observation following establishment of predefined firm guidelines and performance of rigorous rad-path correlation.
Entities:
Keywords:
Atypical lobular hyperplasia; Flat epithelial atypia; High-risk breast lesion; Lobular carcinoma in situ; Mucocele-like lesion; Radial scar
Authors: Peter R Eby; Jennifer E Ochsner; Wendy B DeMartini; Kimberly H Allison; Sue Peacock; Constance D Lehman Journal: Ann Surg Oncol Date: 2008-08-12 Impact factor: 5.344
Authors: Tehillah S Menes; Robert Rosenberg; Steven Balch; Shabnam Jaffer; Karla Kerlikowske; Diana L Miglioretti Journal: Am J Surg Date: 2013-10-07 Impact factor: 2.565
Authors: Zhongliang Ma; Cletus A Arciero; Toncred M Styblo; Haibo Wang; Michael A Cohen; Xiaoxian Li Journal: Breast Cancer Res Treat Date: 2020-07-23 Impact factor: 4.872
Authors: Kimberly H Allison; Linn A Abraham; Donald L Weaver; Anna N A Tosteson; Heidi D Nelson; Tracy Onega; Berta M Geller; Karla Kerlikowske; Patricia A Carney; Laura E Ichikawa; Diana S M Buist; Joann G Elmore Journal: Cancer Date: 2015-01-20 Impact factor: 6.860
Authors: Nour Sneige; Sung C Lim; Gary J Whitman; Savitri Krishnamurthy; Aysegul A Sahin; Terry L Smith; Carol B Stelling Journal: Am J Clin Pathol Date: 2003-02 Impact factor: 2.493
Authors: Michelle C Foster; Mark A Helvie; Nancy E Gregory; Murray Rebner; Alexis V Nees; Chintana Paramagul Journal: Radiology Date: 2004-04-22 Impact factor: 11.105
Authors: Xiaoxian Li; Michael Aho; Mary S Newell; Kelly Clifford; Jay G Patel; Stephanie Jou; Michael A Cohen Journal: Clin Imaging Date: 2019-12-03 Impact factor: 2.420
Authors: Eumee Cha; Emily B Ambinder; Eniola T Oluyemi; Lisa A Mullen; Babita Panigrahi; Joanna Rossi; Philip A Di Carlo; Kelly S Myers Journal: Breast Cancer Res Treat Date: 2022-10-15 Impact factor: 4.624